Dynamesh Medical India Profile
Key Indicators
- Authorised Capital ₹ 1.60 M
- Paid Up Capital ₹ 1.60 M
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -11.20%
- Profit Growth -185.34%
- Ebitda -170.17%
- Net Worth -6.79%
- Total Assets -10.07%
About Dynamesh Medical India
Dynamesh Medical India Private Limited (DMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 November 2007 and has a history of 17 years and three months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.60 M and a paid-up capital of Rs 1.60 M, as per Ministry of Corporate Affairs (MCA) records.
Stefan Schneemelcher, Hrishikesh Rajhansa, Michael Krumbiegel, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100DL2007PTC170045
- Company No.
170045
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Dynamesh Medical India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hrishikesh Rajhansa  | Additional Director | 18-Oct-2019 | Current |
Stefan Schneemelcher  | Director | 01-Nov-2007 | Current |
| Michael Krumbiegel | Director | 15-Jul-2015 | Current |
| Tobias Lang | Additional Director | 13-Jun-2024 | Current |
Financial Performance of Dynamesh Medical India.
Dynamesh Medical India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.2% decrease. The company also saw a substantial fall in profitability, with a 185.34% decrease in profit. The company's net worth dipped by a decrease of 6.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dynamesh Medical India?
In 2023, Dynamesh Medical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Procall Private LimitedHrishikesh Rajhansa is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dynamesh Medical India?
Unlock and access historical data on people associated with Dynamesh Medical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dynamesh Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dynamesh Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
